ViVE 2026: 5 Actionable Priorities for Provider + Payer Leaders

ViVE 2026 made one thing clear: transformation conversations are maturing from “what’s possible” to “what reliably delivers outcomes.” The agenda’s focus on AI, interoperability, and real-world implementation echoed what many executives are already prioritizing—fewer science projects, more measurable progress.

Below are five do-this-next priorities that consistently surfaced across discussions—practical moves that both providers and payers can act on now.

1) Build visibility across the full care journey

Care is decentralizing, but data accountability still breaks down as patients move between acute, post-acute, and home-based settings, creating operational drag and real financial leakage. Build a 12–18 month plan to connect data, event alerts, and shared care planning across partners so every organization operates from the same patient story.

2) Make post-acute integration a strategic priority

Post-acute remains structurally weak for integration—yet it’s pivotal to VBC performance and avoidable utilization. Pick the top post-acute pathways (SNF, home health, hospice) and standardize the data package required for smooth handoffs and outcomes tracking. Then elevate that work as a joint payer-provider operating priority, not just another IT initiative.

3) Operationalize FHIR with governance and repeatable onboarding

FHIR may be “expected,” but adoption is uneven—especially around governance and repeatable vendor onboarding. Create a pragmatic FHIR playbook that defines minimum data sets, versioning rules, security posture, testing gates, and a templated onboarding that scales instead of restarting from zero with every new partner.

4) Put API economics on the CFO dashboard

As API usage grows, so does scrutiny of what each digital transaction actually costs and whether it supports value-based performance - placing it under CFO scrutiny. Track unit economics (cost per member per month, cost per transaction, cost per quality measure automated) and renegotiate where costs don’t map to value delivered.

5) Invest in platforms that turn messy data into defensible ROI

Leaders are favoring platforms that transform diverse clinical, claims, and social data into credible performance insights and measurable financial impact, not point solutions that generate more noise. Moving forward, organizations will win with practical automation that is auditable, regulatory-ready, and embedded in standards-based infrastructure, expanded deliberately through pilots tied to measurable outcomes.

Bottom line: ViVE’s strongest signal wasn’t a new buzzword — it was a higher bar. Providers and payers are done buying “potential.” They’re building toward platforms, governance, and economics that prove impact in the metrics that matter.